A natural plant compound called apigenin reduced fatty liver disease and slowed liver cell aging in mice by blocking a cellular damage pathway called TGF-β/Smad. According to Gram Research analysis, apigenin decreased liver fat accumulation by 40-50%, lowered cholesterol and liver damage markers, and reduced signs of cell aging in treated mice compared to untreated controls. However, this research used mice and laboratory cells, not humans, so human clinical trials are needed before doctors can recommend apigenin as a treatment.
Researchers discovered that apigenin, a natural compound found in plants like chamomile and parsley, may help reverse damage from fatty liver disease. In a study using mice fed a high-fat diet, apigenin reduced fat buildup in the liver, decreased inflammation, and slowed the aging of liver cells. The compound works by blocking a specific cellular pathway that causes liver damage. According to Gram Research analysis, these findings suggest apigenin could become a new treatment option for people with metabolic dysfunction-associated steatotic liver disease, a condition affecting millions worldwide.
Key Statistics
A 2026 laboratory study found that apigenin reduced senescence markers (p16, p21, and γH2AX) in mouse liver tissue and decreased fat accumulation by 40-50% compared to untreated high-fat diet controls.
Research showed that apigenin lowered serum triglycerides, total cholesterol, LDL cholesterol, and liver damage enzymes (AST and ALT) in mice with high-fat diet-induced fatty liver disease.
In cultured liver cells, apigenin reduced senescence-associated β-galactosidase-positive cells by inhibiting the TGF-β/Smad signaling pathway, with effects partially reversed when TGF-β was artificially overexpressed.
Pharmacological inhibition of the TGF-β receptor further enhanced apigenin’s anti-senescence effects and reduced lipid accumulation in liver cells, suggesting pathway combination therapy may be more effective.
The Quick Take
- What they studied: Whether a natural plant compound called apigenin can reduce liver damage and slow aging of liver cells in people with fatty liver disease caused by poor diet and metabolism problems.
- Who participated: The research involved laboratory mice fed a high-fat diet to mimic fatty liver disease in humans, plus liver cells grown in dishes and treated with apigenin.
- Key finding: Apigenin reduced fat accumulation in mouse livers by 40-50%, lowered harmful cholesterol and liver damage markers, and decreased signs of aging liver cells compared to untreated mice.
- What it means for you: This research suggests apigenin might help protect your liver if you have fatty liver disease, but human studies are needed before doctors can recommend it as a treatment. It’s too early to take apigenin supplements based on this study alone.
The Research Details
Scientists conducted two types of experiments to test apigenin’s effects. First, they created fatty liver disease in mice by feeding them a high-fat diet, then gave some mice apigenin while others received no treatment. They examined the mice’s livers under a microscope and measured liver damage markers in their blood. Second, they grew liver cells in laboratory dishes, damaged them with a fatty acid called palmitic acid to mimic disease, then treated some cells with apigenin. This two-pronged approach—testing in living animals and isolated cells—helps confirm whether the compound actually works and how it works at the cellular level.
Using both animal models and cell cultures strengthens the research because it shows the effect happens at multiple biological levels. The mouse model mimics how fatty liver disease develops in humans, while the cell experiments reveal the exact molecular mechanism. This combination helps researchers understand not just whether apigenin works, but precisely how it protects liver cells from damage and aging.
This is a well-designed laboratory study using established research methods. The researchers measured multiple markers of liver health and disease, used proper control groups (untreated mice and cells), and confirmed their findings with multiple testing techniques. However, this is animal and cell research, not human studies, so results may not directly translate to people. The study was published in a peer-reviewed journal, meaning other scientists reviewed it before publication.
What the Results Show
In mice with fatty liver disease, apigenin treatment significantly reduced fat buildup in liver tissue, decreased inflammation, and prevented scarring (fibrosis). Blood tests showed improvements in cholesterol levels, triglycerides, and liver damage markers like AST and ALT enzymes. The compound also reduced three key markers of cell aging (p16, p21, and γH2AX) in liver tissue. In laboratory liver cells, apigenin reduced the number of aged cells by blocking a cellular pathway called TGF-β/Smad, which normally triggers aging and damage. When researchers artificially increased TGF-β expression, apigenin’s protective effects were partially reversed, confirming this pathway is crucial to how the compound works.
Additional experiments showed that blocking the TGF-β pathway with a pharmaceutical inhibitor further enhanced apigenin’s anti-aging effects and reduced fat accumulation in cells. This suggests combining apigenin with TGF-β pathway blockers might be even more effective. The research also demonstrated that apigenin’s benefits weren’t limited to one type of liver damage—it improved multiple aspects of liver health simultaneously, including inflammation, fat storage, and cellular aging.
This research builds on earlier studies showing apigenin has antioxidant and anti-inflammatory properties. Previous research suggested apigenin might help with liver health, but this is the first study to specifically explain how it prevents liver cell aging through the TGF-β pathway. The findings align with growing evidence that natural plant compounds can modulate cellular aging pathways, similar to other flavonoids being studied for liver protection.
This study used mice and laboratory cells, not humans, so results may not directly apply to people. The sample size of mice wasn’t specified in the abstract. The research doesn’t tell us the optimal dose of apigenin for humans or whether it would be safe and effective as a long-term treatment. Additionally, the study didn’t compare apigenin to existing fatty liver disease treatments, so we don’t know if it’s better or worse than current options. More human clinical trials are needed before apigenin can be recommended as a medical treatment.
The Bottom Line
Based on this research, apigenin shows promise as a potential treatment for fatty liver disease, but it’s too early for clinical recommendations. The evidence is strong in laboratory and animal models (high confidence in the mechanism), but human studies are needed. People with fatty liver disease should continue following their doctor’s advice about diet, exercise, and proven treatments rather than self-treating with apigenin supplements.
This research is most relevant to people with metabolic dysfunction-associated steatotic liver disease (fatty liver disease), researchers studying liver disease treatments, and pharmaceutical companies developing new medications. People with obesity, type 2 diabetes, or metabolic syndrome should be aware of this research but shouldn’t change their treatment plans based on it alone. This is not yet applicable to general healthy people.
In the mouse studies, apigenin showed benefits after several weeks of treatment. If apigenin eventually becomes a human treatment, it would likely take months to see improvements in liver health, similar to other liver disease treatments. Don’t expect immediate results—liver healing is a slow process.
Frequently Asked Questions
Can apigenin supplements treat fatty liver disease?
Current research shows apigenin reduced fatty liver disease in mice and laboratory cells, but human studies haven’t been conducted yet. Supplements aren’t proven safe or effective for this condition. Consult your doctor before taking apigenin—proven treatments like weight loss and dietary changes remain the standard approach.
What foods contain apigenin naturally?
Apigenin is found in chamomile tea, parsley, celery, onions, and some other plants. While eating these foods is safe and healthy, the amounts of apigenin in food are much lower than doses used in this research, so food sources alone may not provide therapeutic benefits.
How does apigenin help the liver according to this study?
Apigenin blocks a cellular pathway called TGF-β/Smad that causes liver cells to age and become damaged. By blocking this pathway, apigenin reduces fat buildup, inflammation, and scarring in the liver while slowing the aging of liver cells.
When will apigenin be available as a liver disease treatment?
This research is preliminary—human clinical trials haven’t started yet. If development proceeds, it typically takes 5-10 years from laboratory research to FDA approval. Patients should continue following their doctor’s current treatment recommendations.
Who should be concerned about fatty liver disease?
People with obesity, type 2 diabetes, metabolic syndrome, or those who consume excess alcohol are at higher risk. If you have these conditions, ask your doctor about liver health screening. Maintaining a healthy weight and balanced diet are proven preventive strategies.
Want to Apply This Research?
- Track liver health markers if you have fatty liver disease: monitor your weight weekly, record any changes in energy levels or abdominal bloating daily, and note any follow-up blood test results (AST, ALT, cholesterol levels) when available from your doctor.
- If interested in apigenin-rich foods while awaiting human studies, users could log daily intake of apigenin sources (chamomile tea, parsley, celery, onions) and track any changes in digestion or energy. However, emphasize this is not a substitute for medical treatment.
- Set monthly reminders to check weight and energy levels. If pursuing medical treatment for fatty liver disease, log appointment dates and blood test results. Create a trend chart showing liver enzyme levels over time to discuss with your doctor.
This research describes laboratory and animal studies, not human clinical trials. Apigenin is not currently approved by the FDA as a treatment for fatty liver disease. Do not use apigenin supplements to treat liver disease without consulting your healthcare provider. This article is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. If you have fatty liver disease or metabolic dysfunction, work with your doctor on proven interventions including weight management, dietary changes, and appropriate medications. Always inform your healthcare provider about any supplements you’re considering.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.